共 50 条
- [1] Discovery of SAM competitive, brain-restricted PRMT5 inhibitors with potent antitumor activityABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255Tatlock, JohnBillitti, JosephBraganza, JohnBrooun, AlexeiDeng, Ya-LiHirakawa, BradJensen-Pergakes, KristenKumpf, RobertLiu, WeiMaegley, KarenMcAlpine, IndrawanMcTigue, MichelePatman, RyanRui, EugeneScales, StephanieTran-Dube, MichelleWang, FenWang, ZhenxiongYamazaki, ShinjiZhang, TaoWythes, Martin
- [2] Discovery of PF-06855800, a SAM competitive PRMT5 inhibitor with potent antitumor activityCANCER RESEARCH, 2018, 78 (13)Mcalpine, Indrawan J.Tatlock, JohnBillitti, JosephBraganza, JohnBrooun, AlexeiDeng Ya-LiHirakawa, BradJensen-Pergakes, KristenKumpf, RobertLiu, WeiMaegley, KarenMcTigue, MichelePatman, RyanRui, EugeneScales, StephanieSpiegel, NoahTran-Dube, MichelleWang, FenWang, ZhenxiongYamazaki, ShinjiZhang, TaoWythes, Martin
- [3] Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1940 - 1955Zhang, MengDing, XiaoyuCao, ZhongyingYang, YilinDing, XiaoCai, XinZhang, ManAliper, AlexRen, FengLu, HongfuZhavoronkov, Alex
- [4] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) InhibitorsACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038Lin, HongWang, MinZhang, Yang W.Tong, ShuilongLeal, Raul A.Shetty, RupaVaddi, KrisLuengo, Juan I.
- [5] The discovery and preclinical characterization of the SAM-competitive PRMT5 inhibitor UCT-000445CANCER RESEARCH, 2023, 83 (07)McDermott, Martina S.O'Brien, Neil A.O'Boyle, BrendanBartberger, MichaelLoson, Oliver C.Chau, KevinSchwab, EllaHong, JennyZhou, JiayingHu, ChuhongLuo, TongAyala, RaulGlasby, JohnStoltz, Brian M.Slamon, Dennis J.
- [6] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269Lin, HongLuengo, Juan, I
- [7] Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activityJournal of Computer-Aided Molecular Design, 2019, 33 : 775 - 785Kongkai ZhuJingwei ShaoHongrui TaoXue YanCheng LuoHua ZhangWenhu Duan
- [8] Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activityJOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 33 (08) : 775 - 785Zhu, KongkaiShao, JingweiTao, HongruiYan, XueLuo, ChengZhang, HuaDuan, Wenhu
- [9] Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside AnaloguesJOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (03) : 1662 - 1684Talukdar, ArindamMukherjee, AyanBhattacharya, Debomita
- [10] Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitorsBIOORGANIC CHEMISTRY, 2023, 130Chen, YutingShi, QiongyuYang, HongLi, JiayiZhou, KaixinZhang, JunjieWang, ZekunShi, HuanyuXiong, BingLiu, JiaHuang, XunLiu, Tongchao